Anthem Biosciences Closes Trading Window for Q1 FY27 Results

Anthem Biosciences Ltd has announced the closure of its trading window for all designated persons. This closure is effective from July 01, 2026, and will remain in effect until 48 hours after the board meeting where financial results for the quarter ending June 30, 2026, are approved. The company is adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct. Designated persons have been duly informed not to engage in any trading of the company's securities during this period. The exact date of the board meeting will be communicated to the stock exchanges in due course.